Search clinical trials for: Placebo ( Semaglutide D)
Total 57187 results
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedType 2 Diabetes | Healthy VolunteersUnited States, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SActive, not recruitingEarly Alzheimer's DiseaseCanada, United States, Spain, Netherlands, United Kingdom, Austria, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, Poland, Denmark, Czechia, Ireland, Norway, Japan, Romania, South Africa, Sweden, ... and more
-
Novo Nordisk A/SCompletedHealthy Volunteers (Diabetes Mellitus, Type 2)United Kingdom
-
Novo Nordisk A/SRecruiting
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, Italy, Spain, Canada, Hungary
-
Novo Nordisk A/SCompletedObesity | OverweightJapan, Korea, Republic of
-
Novo Nordisk A/SCompletedOverweight or Obesity | Metabolism and Nutrition DisorderUnited States, India, Mexico, Russian Federation, United Kingdom, Canada, Denmark, Finland, Belgium, Japan, Taiwan, France, Poland, Germany, Bulgaria, Argentina, Puerto Rico
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, India, Japan, Russian Federation, United Kingdom, Canada, Spain, South Africa, Germany, Greece, United Arab Emirates, Argentina, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedObesityUnited States, Israel, United Kingdom, Denmark, Germany, Netherlands, Canada, Argentina, Czechia, Hungary, Poland, Spain, Australia
-
Novo Nordisk A/SCompletedObesity | Diabetes Mellitus, Type 2 | OverweightKorea, Republic of, Hong Kong, Brazil, China
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States
-
Woman'sNovo Nordisk A/SRecruitingPre Diabetes | Postpartum DisorderUnited States
-
Novo Nordisk A/SCompletedType 2 Diabetes | Healthy Volunteers | High Blood Cholesterol LevelsGermany, Canada
-
Novo Nordisk A/SCompletedOverweight and ObesityJapan, Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Hungary, Poland, Russian Federation, Bulgaria, Serbia, Greece, Denmark
-
Novo Nordisk A/SCompletedHealthy Volunteers Type 2 DiabetesJapan
-
Novo Nordisk A/SCompletedObesity | Diabetes Mellitus, Type 2 | Overweight | Healthy VolunteersNetherlands
-
Novo Nordisk A/SCompletedObesityKorea, Republic of, Thailand
-
Novo Nordisk A/SCompletedObesitySpain, United States, France, Russian Federation, Canada, Colombia, South Africa, Norway, Denmark, Saudi Arabia, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States
-
San Francisco Veterans Affairs Medical CenterSuspendedObesity | Overweight | Atrial FibrillationUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Italy, Mexico, United Kingdom, Canada, Denmark, Spain, Netherlands, Malaysia, Taiwan, Germany, Poland, Turkey, Argentina, South Africa, Romania, Thailand, Algeria, Brazil
-
Novo Nordisk A/SCompletedObesity | OverweightGermany
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Poland, Russian Federation, United Kingdom, Denmark, Finland, Sweden
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedA Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, Croatia, Russian Federation, United Kingdom, Belgium, Mexico, Austria, Ireland
-
University Medical Center GroningenNovo Nordisk A/SEnrolling by invitationObesity | AlbuminuriaNetherlands, Germany, Spain, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Mexico, Japan, Serbia, Turkey, Italy, Czechia, Bulgaria, Algeria, Romania
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Israel, Spain, Netherlands, Sweden, Switzerland, South Africa, Denmark, Portugal, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, United Kingdom, Mexico, Russian Federation, Japan, Canada, Italy, South Africa, Romania
-
University of Texas Southwestern Medical CenterUniversity of North Carolina, Chapel HillRecruiting
-
University Health Network, TorontoRecruitingMajor Depressive DisorderCanada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Hungary, Greece
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, Austria, Japan, Norway, Puerto Rico
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesJapan
-
Loma Linda UniversityNovo Nordisk A/SRecruitingObesity | Weight Loss | Overweight or Obesity | Weight, Body | Obesity; Drug | Weight Loss TrajectoryUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy VolunteersChina
-
Case Western Reserve UniversityMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingObesity | HIV/AIDS | LipohypertrophyUnited States
-
Geisinger ClinicNovo Nordisk A/STerminatedDiabetes Mellitus, Type 2United States
-
Universitaire Ziekenhuizen KU LeuvenJessa Hospital; Universitair Ziekenhuis Brussel; University Hospital, Antwerp; AZ... and other collaboratorsRecruitingGlucose Intolerance After a Recent History of Gestational DiabetesBelgium
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Taiwan, Serbia, Algeria, Hungary, China, Ukraine
-
University Medical Centre LjubljanaCompletedPCOS | Gastric Emptying | Semaglutide | Taste, Altered | Tongue Tissue Transcriptome | Central Neural ResponseSlovenia
-
Novo Nordisk A/SCompletedHealthy | DiabetesUnited Kingdom